Skip to main content
Log in

The Fluoxetine and Suicide Controversy

A Review of the Evidence

  • Correspondence
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994; 1: 223–31

    Article  Google Scholar 

  2. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990: 147: 207–10

    PubMed  CAS  Google Scholar 

  3. Beasley CM, Dornseif VE, Postemworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991: 303: 685–92

    Article  PubMed  Google Scholar 

  4. Beasley CM. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. J Affect Disord 1992; 24: 1–10

    Article  PubMed  Google Scholar 

  5. Goldstein DJ, Rampey Jr AH, Potvin JH. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction. J Clin Psychiatry 1993; 54: 309–16

    PubMed  CAS  Google Scholar 

  6. Wheadon DE, Rampey Jr AH, Thompson VL, et al. Lack of association between fluoxetine and suicidality in bulimia nervosa. J Clin Psychiatry 1992; 53: 235–41

    PubMed  CAS  Google Scholar 

  7. PEM Report No 5 (fluoxetine). Drug Safety Research Unit, Southampton, September 1993.

  8. Tollefson GD, Rampey AH, Beasley CM, et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 1994; 14: 163–9

    PubMed  CAS  Google Scholar 

  9. Miller I, Bishop S, Norman W, et al. The modified Hamilton rating scale for depression: reliability and validity. Psychiatry Res 1985; 14: 131–42

    Article  PubMed  CAS  Google Scholar 

  10. Stanley B, Träskman-Bendz L, Stanley M. The suicide assessment scale: a scale evaluating change in suicidal behaviour. Psychopharmacol Bull 1986; 22: 200–5

    PubMed  CAS  Google Scholar 

  11. Miller IW, Norman WH, Bishop SB, et al. The modified scale for suicidal ideation: reliability and validity. J Consult Clin Psychol 1986; 54: 724–5

    Article  PubMed  CAS  Google Scholar 

  12. Damluji NF, Ferguson JM. Paradox of the worsening of depressed symptomatology caused by antidepressants. J Clin Psychopharmacol 1988; 8: 347–9

    Article  PubMed  CAS  Google Scholar 

  13. Richelson E. Antidepressants and brain neurochemistry. Mayo Clin Proc 1990; 65: 1227–36

    PubMed  CAS  Google Scholar 

  14. Rouillon F, Phillips R, Serrurier E, et al. Prophylactic efficacy of maprotilene on relapses of unipolar depression. L’Encephale 1989; 15: 527–34

    PubMed  CAS  Google Scholar 

  15. Price J, Waller P, Wood S, et al. Safety of fluoxetine: comparison with fluvoxamine. Pharmacoepidemiol Drug Saf 1992; 1: 111–7

    Article  Google Scholar 

References

  1. Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994; 1: 223–31

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakielny, J., Healy, D. The Fluoxetine and Suicide Controversy. CNS Drugs 2, 252–254 (1994). https://doi.org/10.2165/00023210-199402030-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199402030-00008

Keywords

Navigation